PolyPeptide Group AG announced the appointment of Lalit Ahluwalia as CFO, effective 1 May 2023, following the resignation of Jan Fuhr Miller. Following the resignation of PolyPeptide's CFO, Jan Fuhr Miller, Lalit Ahluwalia will serve as CFO and member of the Executive Committee effective 1 May 2023, while the Board of Directors together with Mr. Gonzalez initiate the search for a permanent CFO. Mr. Ahluwalia has extensive experience as a financial leader.

His last assignments were from 2010 to January 2023 with Ferring Pharmaceuticals in the United States, initially as CFO for the U.S. companies and later as Vice President of Special Projects globally. He has already begun working with PolyPeptide in February 2023 as the Chief of Staff of the Executive Chairman to support the transition following the resignation of the Group's previous CEO. Jan Fuhr Miller will continue to be available until the end of June 2023 to ensure a smooth hand-over.